To Determine The Efficacy Of Homoeopathic Medicines In Reducing Chronic Plantar Heel Pain

To Determine The Efficacy Of Individualised Homoeopathic Medicines In Reducing Chronic Plantar Heel Pain- A Randomised Double-Blind Placebo Control Trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/10/046546

Enrollment

Registered

2022-10-17

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M796- Pain in limb, hand, foot, fingersand toes

Interventions

Intervention1: Homoeopathic medicines: Double-blind randomised placebo controlled trial conducted by block randomisation and to assess the efficacy of Individualised homoeopathic medicines in reducing

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients presenting with symptoms of chronic plantar heel pain. 2. Patients in the age group of 18-65 years of age. 3. Patient showing clinical or radiological evidence of plantar fasciitis or calcaneal spur.

Exclusion criteria

Exclusion criteria: 1. Patients presenting with acute onset of heel pain (less than three weeks duration) 2. Patients presented with the worst possible pain on the VAS scale 3. Patients showing positive R.A. factor and CRP during the investigation 4. Presenting with any fracture or tumour confirmed by radiological evidence 5. Pregnant or breastfeeding women 6. Have received a corticosteroid injection in the foot during the preceding six months.

Design outcomes

Primary

Measure	Time frame
To determine the reduction in Chronic Plantar Heel Pain with Individualised Homoeopathic Medicines by using Foot Function Index (FFI) score.Timepoint: ENROLLMENT PERIOD- 1 YEAR FOLLOW UP PERIOD- 6 MONTHS	—

Secondary

Measure	Time frame
1. To determine the reduction in disability of patients with Chronic plantar heel pain by assessing the disability subscale of the FFI score 2. To determine the reduction in activity limitation of patients with Chronic plantar heel pain by assessing the activity limitation subscale of the FFI score 3. To evaluate the co-morbidities associated with the condition. 4. To evaluate the recurrence of pain in the patients.Timepoint: ENROLLMENT PERIOD- 1 YEAR FOLLOW UP PERIOD- 6 MONTHS	—

Measure

Time frame

1. To determine the reduction in disability of patients with Chronic plantar heel pain by assessing the disability subscale of the FFI score 2. To determine the reduction in activity limitation of patients with Chronic plantar heel pain by assessing the activity limitation subscale of the FFI score 3. To evaluate the co-morbidities associated with the condition. 4. To evaluate the recurrence of pain in the patients.Timepoint: ENROLLMENT PERIOD- 1 YEAR FOLLOW UP PERIOD- 6 MONTHS

—

Countries

India

Contacts

Public ContactDr P Dastagiri

National Homoeopathy Research Institute In Mental Health, Kurichy, Kottayam

drdastagirinhrimh@gmail.com9000444409

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026